{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T17:39:32Z","timestamp":1769017172251,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.cardfail.2005.05.007","type":"journal-article","created":{"date-parts":[[2005,10,16]],"date-time":"2005-10-16T11:03:40Z","timestamp":1129460620000},"page":"602-606","source":"Crossref","is-referenced-by-count":42,"title":["High Prevalence of Microalbuminuria in Chronic Heart Failure Patients"],"prefix":"10.1016","volume":"11","author":[{"given":"Ruud M.A.","family":"van de Wal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folkert W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.W. Thijs","family":"Plokker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom D.J.","family":"Smilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiek H.","family":"van Gilst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan A.","family":"Voors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2005.05.007_bib1","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2005.05.007_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2005.05.007_bib3","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","article-title":"Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III","volume":"61","author":"Garg","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2005.05.007_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2796.2001.00833.x","article-title":"Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity","volume":"249","author":"Hillege","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.cardfail.2005.05.007_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/00365519209088785","article-title":"Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition","volume":"52","author":"Eiskjaer","year":"1992","journal-title":"Scand J Clin Lab Invest"},{"issue":"Suppl 1","key":"10.1016\/j.cardfail.2005.05.007_bib6","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/01.ASN.0000093235.09769.9C","article-title":"Angiotensin-converting enzyme inhibitors versus AT1 receptor antagonist in cardiovascular and renal protection: the case for AT1 receptor antagonist","volume":"15","author":"Berl","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2005.05.007_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.cardfail.2005.05.007_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ndt\/18.1.10","article-title":"Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase?","volume":"18","author":"de Jong","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cardfail.2005.05.007_bib9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000054165.93055.42","article-title":"Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"107","author":"Arnold","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2005.05.007_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2005.05.007_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ki.1980.59","article-title":"Albuminuria and the permselective properties of the glomerulus in cardiac failure","volume":"17","author":"Carrie","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.cardfail.2005.05.007_bib12","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1681\/ASN.V11101882","article-title":"Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population","volume":"11","author":"Pinto-Sietsma","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2005.05.007_bib13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/hy1201.096528","article-title":"Radial artery flow-mediated dilatation in heart failure patients: effects of pharmacological and nonpharmacological treatment","volume":"38","author":"Giannattasio","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2005.05.007_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.102.3.351","article-title":"Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure: role of nitric oxide, prostanoids, oxidant stress, and bradykinin","volume":"102","author":"Varin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2005.05.007_bib15","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0735-1097(03)00403-0","article-title":"Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study","volume":"41","author":"Liu","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2005.05.007_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1067\/mhj.2001.113223","article-title":"A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study","volume":"141","author":"Devereux","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2005.05.007_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2005.05.007_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2005.05.007_bib19","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2005.05.007_bib20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/ajkd.2002.33388","article-title":"Albumin to creatinine ratio: a screening test with limitations","volume":"39","author":"Houlihan","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916405002381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916405002381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T16:11:40Z","timestamp":1626624700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916405002381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1071916405002381"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2005.05.007","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}